We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+16.7%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$77.4B
AUM Growth
+$4.82B
Cap. Flow
-$6.74B
Cap. Flow %
-8.71%
Top 10 Hldgs %
8.98%
Holding
4,169
New
447
Increased
1,310
Reduced
1,599
Closed
617

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$436M
2
ABBV icon
AbbVie
ABBV
+$407M
3
JNJ icon
Johnson & Johnson
JNJ
+$295M
4
GILD icon
Gilead Sciences
GILD
+$267M
5
SBUX icon
Starbucks
SBUX
+$230M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$407M
2
BKNG icon
Booking.com
BKNG
+$400M
3
C icon
Citigroup
C
+$314M
4
SHPG
Shire pic
SHPG
+$276M
5
PYPL icon
PayPal
PYPL
+$257M

Sector Composition

Rank Sector Weight
1 Technology 17.04%
2 Healthcare 13.44%
3 Consumer Discretionary 13.38%
4 Financials 7.19%
5 Industrials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASNA
3376
DELISTED
Ascena Retail Group, Inc.
ASNA
$175K ﹤0.01%
8,086
+3,699
+84% +$166K
LQDT icon
3377
Liquidity Services
LQDT
$1.35B
$174K ﹤0.01%
22,616
-11,684
-34% -$87.5K
ABUS icon
3378
Arbutus Biopharma
ABUS
$1.02B
$172K ﹤0.01%
48,047
ESTE
3379
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$166K ﹤0.01%
23,461
-45,338
-66% -$292K
AG icon
3380
PUT
First Majestic Silver
AG
$10.4B
$165K ﹤0.01%
25,000
-9,000
-26% -$56.3K
IOTS
3381
DELISTED
Adesto Technologies Corp
IOTS
$163K ﹤0.01%
+26,948
New +$150K
SBT
3382
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$162K ﹤0.01%
15,930
+2,938
+23% +$27.1K
CBAY
3383
DELISTED
Cymabay Therapeutics
CBAY
$162K ﹤0.01%
12,204
+1,738
+17% +$18.5K
NVGS icon
3384
Navigator Holdings
NVGS
$1.36B
$161K ﹤0.01%
14,678
-18,344
-56% -$188K
ADXS
3385
DELISTED
Advaxis Inc
ADXS
$159K ﹤0.01%
26,857
-3
-0% -$17
IO
3386
DELISTED
ION Geophysical Corporation
IO
$156K ﹤0.01%
+10,789
New +$126K
PFX icon
3387
PhenixFIN
PFX
$102M
$155K ﹤0.01%
2,497
+1,672
+203% +$105K
CJ
3388
CALL
DELISTED
C&J Energy Services, Inc.
CJ
$155K ﹤0.01%
10,000
-6,700
-40% -$108K
DO
3389
DELISTED
Diamond Offshore Drilling
DO
$155K ﹤0.01%
+14,823
New +$157K
VTVT icon
3390
vTv Therapeutics
VTVT
$135M
$154K ﹤0.01%
2,245
+487
+28% +$47.2K
DVAX
3391
PUT
DELISTED
Dynavax Technologies
DVAX
$152K ﹤0.01%
+20,800
New +$203K
SYRE icon
3392
Spyre Therapeutics
SYRE
$9.55B
$152K ﹤0.01%
+756
New +$158K
DF
3393
PUT
DELISTED
Dean Foods Company
DF
$152K ﹤0.01%
+50,000
New +$201K
MNR
3394
DELISTED
Monmouth Real Estate Investment Corp
MNR
$152K ﹤0.01%
11,566
-32,965
-74% -$437K
RJET
3395
Republic Airways Holdings
RJET
$885M
$148K ﹤0.01%
1,185
-4,129
-78% -$550K
CUZ icon
3396
Cousins Properties
CUZ
$4.94B
$146K ﹤0.01%
3,768
-208,224
-98% -$7.62M
WPX
3397
DELISTED
WPX Energy, Inc.
WPX
$146K ﹤0.01%
11,100
-18,101
-62% -$227K
CLAR icon
3398
Clarus
CLAR
$144M
$145K ﹤0.01%
+11,397
New +$128K
CORT icon
3399
Corcept Therapeutics
CORT
$13.2B
$144K ﹤0.01%
12,272
-518,511
-98% -$6.44M
PAAS icon
3400
CALL
Pan American Silver
PAAS
$22.2B
$138K ﹤0.01%
10,400

Similar funds

David Shaw's Q1 2019 Portfolio in Review

As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, David Shaw opened a new position in Lyft worth $159M.

  • David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
  • David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
  • David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
  • David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
  • David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
  • David Shaw opened 447 new positions and closed 617 in Q1 2019.
  • David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.